Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia

ConclusionTesting for del(17p) and TP53 variants identifies high‐risk CLL that requires specialist management.

Source: Internal Medicine Journal - December 17, 2017 Category: Internal Medicine Authors: Bryone J. Kuss, Constantine S. Tam Tags: Review Source Type: research